chr1-21471769-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_032264.6(NBPF3):​c.647A>C​(p.Gln216Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)

Consequence

NBPF3
NM_032264.6 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0990
Variant links:
Genes affected
NBPF3 (HGNC:25076): (NBPF member 3) This gene is a member of the neuroblastoma breakpoint family (NBPF) which consists of dozens of recently duplicated genes primarily located in segmental duplications on human chromosome 1. This gene family has experienced its greatest expansion within the human lineage and has expanded, to a lesser extent, among primates in general. Members of this gene family are characterized by tandemly repeated copies of DUF1220 protein domains. DUF1220 copy number variations in human chromosomal region 1q21.1, where most DUF1220 domains are located, have been implicated in a number of developmental and neurogenetic diseases such as microcephaly, macrocephaly, autism, schizophrenia, cognitive disability, congenital heart disease, neuroblastoma, and congenital kidney and urinary tract anomalies. Altered expression of some gene family members is associated with several types of cancer. This gene family contains numerous pseudogenes. [provided by RefSeq, Feb 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.16799861).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NBPF3NM_032264.6 linkuse as main transcriptc.647A>C p.Gln216Pro missense_variant 5/15 ENST00000318249.10 NP_115640.1 Q9H094-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NBPF3ENST00000318249.10 linkuse as main transcriptc.647A>C p.Gln216Pro missense_variant 5/151 NM_032264.6 ENSP00000316782.5 Q9H094-1
NBPF3ENST00000434838.6 linkuse as main transcriptn.*1235A>C non_coding_transcript_exon_variant 9/195 ENSP00000391865.2 X6RCV0
NBPF3ENST00000434838.6 linkuse as main transcriptn.*1235A>C 3_prime_UTR_variant 9/195 ENSP00000391865.2 X6RCV0

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
34
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 25, 2024The c.647A>C (p.Q216P) alteration is located in exon 5 (coding exon 4) of the NBPF3 gene. This alteration results from a A to C substitution at nucleotide position 647, causing the glutamine (Q) at amino acid position 216 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.34
BayesDel_addAF
Benign
-0.037
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
6.1
DANN
Benign
0.90
DEOGEN2
Benign
0.090
.;.;T;.
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.0024
N
LIST_S2
Benign
0.81
T;T;T;T
M_CAP
Benign
0.0014
T
MetaRNN
Benign
0.17
T;T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.7
.;L;L;.
PrimateAI
Uncertain
0.57
T
PROVEAN
Uncertain
-3.1
D;D;D;.
REVEL
Benign
0.15
Sift
Benign
0.13
T;T;T;.
Sift4G
Uncertain
0.016
D;D;D;D
Polyphen
0.99, 0.97
.;D;D;.
Vest4
0.28
MutPred
0.18
.;Gain of glycosylation at Q216 (P = 0.0384);Gain of glycosylation at Q216 (P = 0.0384);.;
MVP
0.38
MPC
0.15
ClinPred
0.29
T
GERP RS
-1.5
Varity_R
0.17
gMVP
0.17

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr1-21798262; API